{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-21-009965","form_type":"8-K","ticker":"GTBP","cik":"0000109657","company_name":"GT Biopharma, Inc.","filed_at":"2021-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.141581+00:00","generated_at":"2026-06-29T04:04:49.075032+00:00","sec_items":["8.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"GT Biopharma holds business teleconference on Sep 13, 2021; presentation slide content not disclosed","bullets":["Company presented business overview via teleconference on September 13, 2021.","Presentation filed as Exhibit 99.1 but no substantive financial or operational details were included in the 8-K.","No earnings, guidance, or material events disclosed in the filing.","The event appears to be a routine investor update; no specific facts available."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-21-009965","json":"https://secwatch.observer/filing/0001654954-21-009965.json","markdown":"https://secwatch.observer/filing/0001654954-21-009965.md","text":"https://secwatch.observer/filing/0001654954-21-009965.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/109657/000165495421009965/0001654954-21-009965-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/109657/000165495421009965/gtbp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T04:04:49.075032+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}